Loading...
Guest User
Welcome! Please login.
* - Tentative Dates
The company intend to utilize the gross proceeds raised through the Issue for the following objects:
Vineet Laboratories Limited's revenue decreased by 50% and profit after tax (PAT) dropped by 2066% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Total Income | 24.86 | 75.00 | 150.59 |
| Profit After Tax | -0.47 | -20.19 | 1.03 |
| NET Worth | 14.22 | 3.30 | 23.49 |
| Reserves and Surplus | 5.00 | -5.92 | 14.27 |
| Amount in ₹ Crore | |||
Vineet Laboratories Limited operates in the pharmaceutical sector, specializing in the production of active pharmaceutical ingredients (APIs) and intermediates. The company serves both domestic and global markets, supplying to regulated as well as semi-regulated pharmaceutical segments.
With a strong emphasis on regulatory compliance, operational efficiency, and sustainable manufacturing, Vineet Laboratories Limited enables pharmaceutical formulators to meet their requirements by offering reliable, high-quality products across various therapeutic areas through its robust manufacturing infrastructure.
